Status:
RECRUITING
Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer
Lead Sponsor:
Seoul National University Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
25-80 years
Brief Summary
In women with newly diagnosed breast cancer, synchronous contralateral breast cancer is reported in 1% to 3%. During the initial diagnosis of breast cancer, it is important to detect the contralateral...
Detailed Description
* This is a multicenter, intraindividual comparative cohort study. * A total of 1098 women with newly diagnosed breast cancer will be enrolled in this study. * Each eligible woman with newly diagnosed...
Eligibility Criteria
Inclusion
- Women aged more than 25 years at the time of enrollment
- Women underwent digital mammography and whole-breast US before MRI
- Women with image-guided biopsy result of invasive breast cancer
- Women who are planning for breast conservation surgery
- Women who will undergo preoperative breast MRI
Exclusion
- Women aged less than 25 years at the time of enrollment
- Women with image-guided biopsy result of ductal carcinoma in situ or recurrent breast cancer
- Women who underwent lumpectomy before MRI
- Women receiving neoadjuvant chemotherapy or undergoing chemotherapy due to other malignancy
- Pregnant or lactating women
- Women with contraindication to breast MRI (claustrophobia, renal insufficiency GFR \<60mL/min/1.73m2, metallic foreign body, history of severe side effects due to MR contrast agent, who cannot tolerate 40 minute scanning time etc).
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
1098 Patients enrolled
Trial Details
Trial ID
NCT05307757
Start Date
May 1 2022
End Date
January 31 2026
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea